The results of our unselected cohort 1413 bladder, 810 kidney cancer cases and 4702 controls revealed no statistical significant, indicating that two mutations of PALB2 gene (509_510delGA and 172_175delTTGT) do not seem to play a major role in bladder or kidney cancer development. The gene discussed is PALB2; the disease is kidney cancer.